AtriCure’s Strong Q3 and Upgraded Outlook Support a Buy Rating as Price Target Rises to $70
at www.tipranks.com (Wed, 4-Nov 8:38 AM)
AtriCure Non-GAAP EPS of $0.18 beats by $0.17, revenue of $154.5M beats by $3.31M
at seekingalpha.com (Tue, 3-Nov 4:05 PM)
Here are the major earnings after the close Tuesday
at seekingalpha.com (Tue, 3-Nov 10:00 AM)
